Short-term postoperative neurocognitive safety and recovery profiles of remimazolam tosilate combined with flumazenil vs. propofol in cirrhotic patients undergoing endoscopic variceal treatment: a randomized controlled trial - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Analysis of Short-term Neurocognitive Outcomes and Recovery in Cirrhotic Patients Undergoing Endoscopic Variceal Procedures: Remimazolam Tosilate with Flumazenil Versus Propofol in a Randomized Controlled Trial

  • By

  • Yanjie Chen

  • Xiangrong Du

  • Fu Shi

  • Na Zhu

  • September 4, 2026

Share

Original Source(s)

Short-term postoperative neurocognitive safety and recovery profiles of remimazolam tosilate combined with flumazenil vs. propofol in cirrhotic patients undergoing endoscopic variceal treatment: a randomized controlled trial

  • by Yanjie Chen, Xiangrong Du, Fu Shi, Na Zhu

  • September 4, 2026

Related Content

SCO‑792 alleviates HFD‑aggravated chronic pancreatitis by modulating the gut–pancreas axis via the AMPK/ACC and TLR4/NF‑κB signaling pathways

Commentary: Assessment of treatment effectiveness, follow-up results, and recurrence patterns in children with Helicobacter pylori infection

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

  • by

  • September 4, 2026

  • 4 min